QNCX – quince therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference
Quince Therapeutics, Inc. (NASDAQ: QNCX) had its price target lowered by analysts at D. Boral Capital from $12.00 to $4.00. They now have a "buy" rating on the stock.
Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
Quince Therapeutics, Inc. (NASDAQ: QNCX) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $10.00 price target on the stock.
Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia [Yahoo! Finance]
Form PRE 14A Quince Therapeutics, For: Dec 31
Form S-8 Quince Therapeutics,
Form 424B5 Quince Therapeutics,
Form 10-K Quince Therapeutics, For: Dec 31
Form 8-K Quince Therapeutics, For: Mar 24
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.